Rituximab in the treatment of non-Hodgkin’s lymphoma

Beate Hauptrock, Georg HessHematology/Oncology, Johannes Gutenberg-University, Mainz, GermanyAbstract: Besides traditional cytostatic drugs the introduction of monoclonal antibodies has substantially influenced current treatment concepts of non-Hodgkin’s lymphoma (NHL).  R...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Beate Hauptrock, Georg Hess
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/e9b43300eff141579113ef98d7a86425
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!